The FOCUS healthcare team represents medical practices and ancillary businesses in specialties where private equity-backed consolidation is occurring. We track activity in key verticals and maintain strong relationships with private equity firms and their portfolio companies.
EyeSouth is One of the Most Active Ophthalmology Practice Management Companies with 23 Acquisitions Since 2017
We profile investors to provide our clients with an important understanding of the types of private equity firms, independent investors, and family offices active in the healthcare verticals we work in every day. Although it is not feasible to create case studies for every investor, we profile those that represent the most active practices common in today’s acquisition market.
Our services are designed to provide exceptional investment banking services to specialty practices and ASCs across a wide range of practice specialties.
Despite the “pause” created by the COVID-19 pandemic, our partner engagements have remained strong. Since July of 2019 FOCUS Managing Directors have completed nine transactions for a combined 16 clinical businesses.
Washington, DC, (June 4, 2021) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Microconsult, Inc., a Carrollton, Texas-based industry leader in cosmetic, supplement and personal care product testing, has been acquired by Certified Laboratories, a Melville, New York-based operator of food, supplements, cosmetic, and personal care laboratories. FOCUS represented Microconsult in this transaction.
Washington, DC, (May 10, 2021) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that Physicians First, a Nashville, Tennessee-based boutique investment banking firm focused on healthcare, has merged its practice into FOCUS. Physicians First founders Eric Yetter and Andy Snyder are joining FOCUS as Managing Directors. Yetter will lead the FOCUS Healthcare Team.
Transaction Volume Continues to Increase Across Behavioral Health
The first quarter of 2021 delivered 38 reported behavioral health transactions, an increase over any quarter in 2020. We expect some of this activity reflects deals that were delayed due to COVID-19. However, we generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact.
Core Dermatology Buyers Remain Active to Start 2021. Window of Opportunity May Be Starting to Close for Smaller Practices.
The first quarter of 2021 delivered five reported dermatology practice acquisitions. This activity decline may signal that the window of opportunity for small practice deals may be starting to close. Indeed, dermatology consolidation is now in its tenth year. However, Schweiger, Epiphany, and Anne Arundel continued to acquire smaller add-on practices and grow their platforms.
Private Equity Interest in ENT & Allergy Practices Accelerates. Expect Increasing Opportunity for Large Practice Sellers.
The first quarter of 2021 delivered five reported ENT practice acquisitions marking the most active three-month M&A period we have seen in the specialty. Notably, Audax Private Equity formally named its portfolio company “Elevate ENT” and expanded into Texas with the major acquisition of Texas ENT Specialists. While the next quarter may not produce as many deals, activity should remain high throughout this year.